Biodegradable Devices for IBD Market Size is valued at USD 119.7 Mn in 2025 and is predicted to reach USD 753.1 Mn by the year 2034 at a 20.6% CAGR during the forecast period for 2026 to 2035.
Biodegradable Devices for IBD Market Size, Share & Trends Analysis Distribution by Disease Type (Crohn’s Disease and Ulcerative Colitis), By Product Type (Tissue Barriers, Wound Dressings, Drug Delivery Systems, Biodegradable Stents, Sutures / Staples, Implants & Patches, Anti-Adhesive, Scaffolds, Surgical Meshes, and Others), By Material Type (Polylactic Acid (PLA), Polyhydroxyalkanoates (PHA), Polyglycolic Acid (PGA), Polycaprolactone (PCL), and Others), By Technology (3D Printing, Biohybrid / Robotics, Nanotechnology, Capsule Endoscopy for IBD Diagnosis and Therapy), By Application (Inflammatory Bowel Disease (IBD) Treatment & Management, Drug Delivery for IBD, and Others), By End-user (Hospitals & Clinics, Ambulatory Surgical Centers, Research and Academic Institutes), and Segment Forecasts, 2026 to 2034
Inflammatory bowel disease (IBD) biodegradable medical implants or therapeutic delivery systems are designed in such a way as to safely biodegrade in the body after fulfilling their intended use, thereby making it unnecessary to undergo surgery for removal. Biodegradable polymers or bioresorbable materials are often utilized for making such devices, which then disintegrate into non-toxic components. These devices find their applications in the management of IBD and tissue healing scaffolding for various conditions such as Crohn’s disease and ulcerative colitis, stenting, and drug delivery systems. The rising number of cases related to inflammatory bowel diseases such as Crohn’s and ulcerative colitis, as well as the rapidly increasing need for modern and convenient treatment options, is responsible for the growth of the global biodegradable devices for IBD market.
The use of biodegradable devices in the treatment of IBD has been advanced even further by the increasing need for targeted approaches to the administration of medications and minimally invasive therapies, which are driving the market growth. Furthermore, the market for biodegradable devices in IBD has experienced steady growth in recent years because of advancements in drug delivery and biodegradable material development. Moreover, rising investments in gastrointestinal research and advancements in biodegradable polymers make it possible to create devices that can deliver anti-inflammatory drugs directly to the affected areas of the intestine.
In addition, the increasing global incidence of chronic gastrointestinal disorders is further driving the biodegradable devices for IBD market growth. On the other hand, technological advancements remain one of the major factors contributing to the development of biodegradable devices for IBD. The performance, safety, and degradation properties of biodegradable devices for IBD have been improved due to advances in areas such as tissue engineering and nanotechnology. Moreover, their clinical applications have been enhanced due to their combined use with intelligent drug delivery systems, which respond to specific physiological conditions present in the gastrointestinal tract.
Which are the Leading Players in the Biodegradable Devices for IBD Market?
• Arthrex
• Braun
• Conmed
• Exactech
• Aesculap Implant Systems
• Bioretec
• Integra Life Sciences
• Osteomed
• Stryker
• Medtronic
• Smith and Nephew
• NuVasive
• Orthofix Medical
• Wright Medical
The global biodegradable devices for IBD market is expected to grow rapidly due to advancements in biomaterials. The discovery of biodegradable materials has created new opportunities for Inflammatory bowel disease (IBD) medical implants, and these are essential to the creation of medical devices. These biodegradable biomaterials are designed to break down organically over time in the body without any negative side effects.
The businesses are producing biodegradable implants with cutting-edge technologies. Additionally, the companies are receiving authorization for treatments and implants that employ a range of biodegradable materials. Furthermore, advancements in polycaprolactone (PCL), polylactic acid (PLA), and polyglycolic acid (PGA) have improved implant efficacy and safety. Because of their superior biocompatibility, these materials are less likely to cause inflammation or rejection.
The biodegradable devices for the IBD market are significantly hampered by the uncertainties surrounding material performance and degradation management in the gastrointestinal tract. The disintegration rate and structural integrity of biodegradable devices can be greatly impacted by the highly diverse conditions found in the human gut, which include varying pH levels, digestive enzymes, moisture, and mechanical stress from peristalsis.
On the other hand, delayed or uneven degradation might result in partial drug release, obstruction, or local discomfort. If a device degrades too quickly, it may stop working before providing the desired therapeutic benefit. The market for biodegradable devices for IBD may not expand as much overall due to its intricacy, which may restrict widespread acceptance and slow regulatory clearances.
The Crohn's disease category held the largest share in the Biodegradable Devices for IBD market in 2025 because Crohn's disease is becoming more commonplace worldwide, and there is a growing demand for cutting-edge, patient-friendly treatment alternatives.
The need for biodegradable stents, localized medication delivery systems, and temporary implants that don't need to be surgically removed has increased because Crohn's disease frequently results in chronic inflammation, strictures, and fistulas that necessitate repeated operations. By delivering targeted therapy directly to inflamed intestinal tissues, these devices improve long-term disease management and lessen procedure-related problems.
In 2025, the Polylactic Acid (PLA) category dominated the Biodegradable Devices for IBD market because of its good biocompatibility, consistent biodegradation profile, and widespread use in medicinal applications. Since PLA-based materials safely break down into lactic acid, which the body naturally metabolizes, they are becoming more and more popular in the production of biodegradable drug delivery systems, temporary intestinal stents, and implantable scaffolds used in the treatment of IBD. Additionally, the use of PLA-based devices is being further accelerated by the increasing prevalence of IBD worldwide as well as the growing need for minimally invasive and patient-friendly therapeutic options.
The Biodegradable Devices for IBD market was dominated by the North America region in 2025 because of the region's improved health care infrastructure, high rates of use of cutting-edge medical items, and the established presence of entry-level businesses. The region has seen significant expenditures in research and development, the adoption of favourable legislative frameworks, and an increase in patient and medical community awareness of the benefits of biodegradable solutions.
Furthermore, the biodegradable devices for the IBD market are growing because inflammatory bowel conditions like Crohn's and ulcerative colitis are more common in this area. Additionally, the presence of specialized manufacturing and strong collaboration between medical technology firms and research facilities contributes to the degree of product innovation, which is a compelling argument for North America's supremacy in the global market.
| Report Attribute | Specifications |
| Market size value in 2025 | USD 119.7 Mn |
| Revenue forecast in 2035 | USD 753.1 Mn |
| Growth Rate CAGR | CAGR of 20.6% from 2026 to 2035 |
| Quantitative Units | Representation of revenue in US$ Bn and CAGR from 2026 to 2035 |
| Historic Year | 2022 to 2024 |
| Forecast Year | 2026-2035 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | Disease Type, Product Type, Material Type, Technology, Application, End-user, and By Region |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
| Competitive Landscape | Arthrex, B. Braun, Conmed, Exactech, Aesculap Implant Systems, Bioretec, Integra Life Sciences, Osteomed, Stryker, Medtronic, Smith and Nephew, Nu Vasive, Orthofix Medical, and Wright Medical. |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Geographic competitive landscape. |
| Pricing and Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Biodegradable Devices for IBD Market by Disease Type-
• Crohn’s Disease
• Ulcerative Colitis
Biodegradable Devices for IBD Market by Product Type-
• Tissue Barriers
• Wound Dressings
• Drug Delivery Systems
• Biodegradable Stents
• Sutures / Staples
• Implants & Patches
• Anti-Adhesive
• Scaffolds
• Surgical Meshes
• Others
Biodegradable Devices for IBD Market by Material Type-
• Polylactic Acid (PLA)
• Polyhydroxyalkanoates (PHA)
• Polyglycolic Acid (PGA)
• Polycaprolactone (PCL)
• Others
Biodegradable Devices for IBD Market by Technology-
• 3D Printing
• Biohybrid / Robotics
• Nanotechnology
• Capsule Endoscopy for IBD Diagnosis and Therapy
Biodegradable Devices for IBD Market by Application-
• Inflammatory Bowel Disease (IBD) Treatment & Management
• Drug Delivery for IBD
• Others
Biodegradable Devices for IBD Market by End-user-
• Hospitals & Clinics
• Ambulatory Surgical Centers
• Research and Academic Institutes
By Region-
North America-
• The US
• Canada
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Mexico
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Biodegradable Devices for IBD Market Snapshot
Chapter 4. Global Biodegradable Devices for IBD Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2025-2034
4.8. Global Biodegradable Devices for IBD Market Penetration & Growth Prospect Mapping (US$ Mn), 2024-2034
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2024)
4.10. Use/impact of AI on BIODEGRADABLE DEVICES FOR IBD MARKET Industry Trends
Chapter 5. Global Biodegradable Devices for IBD Market Segmentation 1: By Type of Product, Estimates & Trend Analysis
5.1. Market Share By Type of Product, 2025 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Type of Product:
5.2.1. Drug Delivery Systems
5.2.2. Biodegradable Stents
5.2.3. Sutures / Staples
5.2.4. Surgical Meshes
5.2.5. Implants & Patches
5.2.6. Anti-Adhesive
5.2.7. Tissue Barriers
5.2.8. Wound Dressings
5.2.9. Scaffolds
5.2.10. Others
Chapter 6. Global Biodegradable Devices for IBD Market Segmentation 2: By Type of Technology, Estimates & Trend Analysis
6.1. Market Share By Type of Technology, 2025 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Type of Technology:
6.2.1. 3D Printing
6.2.2. Nanotechnology
6.2.3. Biohybrid / Robotics
6.2.4. Capsule Endoscopy for IBD Diagnosis and Therapy
Chapter 7. Global Biodegradable Devices for IBD Market Segmentation 3: By Application Area, Estimates & Trend Analysis
7.1. Market Share By Application Area, 2025 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Application Area:
7.2.1. Inflammatory Bowel Disease (IBD) Treatment & Management
7.2.2. Drug Delivery for IBD
7.2.3. Other Applications
Chapter 8. Global Biodegradable Devices for IBD Market Segmentation 4: By Type of Disease, Estimates & Trend Analysis
8.1. Market Share By Type of Disease, 2025 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Type of Disease:
8.2.1. Crohn’s Disease
8.2.2. Ulcerative Colitis
Chapter 9. Global Biodegradable Devices for IBD Market Segmentation 5: ByType of Material, Estimates & Trend Analysis
9.1. Market Share ByType of Material, 2025 & 2035
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the followingType of Material:
9.2.1. Polylactic Acid (PLA)
9.2.2. Polyglycolic Acid (PGA)
9.2.3. Polycaprolactone (PCL)
9.2.4. Polyhydroxyalkanoates (PHA)
9.2.5. Others
Chapter 10. Global Biodegradable Devices for IBD Market Segmentation 6: By End User, Estimates & Trend Analysis
10.1. Market Share By End User, 2025 & 2035
10.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following End User:
10.2.1. Hospitals
10.2.2. Ambulatory Surgical Centers
10.2.3. Clinics
10.2.4. Research and Academic Institutes
Chapter 11. Global Biodegradable Devices for IBD Market Segmentation 7: Regional Estimates & Trend Analysis
11.1. Global Biodegradable Devices for IBD Market, Regional Snapshot 2022 & 2035
11.2. North America
11.2.1. North America Biodegradable Devices for IBD Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022-2035
11.2.1.1. US
11.2.1.2. Canada
11.2.2. North America Biodegradable Devices for IBD Market Revenue (US$ Million) Estimates and Forecasts By Type of Product, 2022-2035
11.2.3. North America Biodegradable Devices for IBD Market Revenue (US$ Million) Estimates and Forecasts By Application Area, 2022-2035
11.2.4. North America Biodegradable Devices for IBD Market Revenue (US$ Million) Estimates and Forecasts By Type of Technology, 2022-2035
11.2.5. North America Biodegradable Devices for IBD Market Revenue (US$ Million) Estimates and Forecasts By Type of Disease, 2022-2035
11.2.6. North America Biodegradable Devices for IBD Market Revenue (US$ Million) Estimates and Forecasts By Type of Material, 2022-2035
11.2.7. North America Biodegradable Devices for IBD Market Revenue (US$ Million) Estimates and Forecasts By End User, 2022-2035
11.3. Europe
11.3.1. Europe Biodegradable Devices for IBD Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022-2035
11.3.1.1. Germany
11.3.1.2. U.K.
11.3.1.3. France
11.3.1.4. Italy
11.3.1.5. Spain
11.3.1.6. Rest of Europe
11.3.2. Europe Biodegradable Devices for IBD Market Revenue (US$ Million) Estimates and Forecasts By Type of Product, 2022-2035
11.3.3. Europe Biodegradable Devices for IBD Market Revenue (US$ Million) Estimates and Forecasts By Application Area, 2022-2035
11.3.4. Europe Biodegradable Devices for IBD Market Revenue (US$ Million) Estimates and Forecasts By Type of Technology, 2022-2035
11.3.5. Europe Biodegradable Devices for IBD Market Revenue (US$ Million) Estimates and Forecasts By Type of Disease, 2022-2035
11.3.6. Europe Biodegradable Devices for IBD Market Revenue (US$ Million) Estimates and Forecasts By Type of Material, 2022-2035
11.3.7. Europe Biodegradable Devices for IBD Market Revenue (US$ Million) Estimates and Forecasts By End User, 2022-2035
11.4. Asia Pacific
11.4.1. Asia Pacific Biodegradable Devices for IBD Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022-2035
11.4.1.1. India
11.4.1.2. China
11.4.1.3. Japan
11.4.1.4. Australia
11.4.1.5. South Korea
11.4.1.6. Hong Kong
11.4.1.7. Southeast Asia
11.4.1.8. Rest of Asia Pacific
11.4.2. Asia Pacific Biodegradable Devices for IBD Market Revenue (US$ Million) Estimates and Forecasts By Type of Product, 2022-2035
11.4.3. Asia Pacific Biodegradable Devices for IBD Market Revenue (US$ Million) Estimates and Forecasts By Application Area, 2022-2035
11.4.4. Asia Pacific Biodegradable Devices for IBD Market Revenue (US$ Million) Estimates and Forecasts By Type of Technology, 2022-2035
11.4.5. Asia Pacific Biodegradable Devices for IBD Market Revenue (US$ Million) Estimates and Forecasts By Type of Disease, 2022-2035
11.4.6. Asia Pacific Biodegradable Devices for IBD Market Revenue (US$ Million) Estimates and Forecasts By Type of Material, 2022-2035
11.4.7. Asia Pacific Biodegradable Devices for IBD Market Revenue (US$ Million) Estimates and Forecasts By End User, 2022-2035
11.5. Latin America
11.5.1. Latin America Biodegradable Devices for IBD Market Revenue (US$ Million) Estimates and Forecasts by Country, 2022-2035
11.5.1.1. Brazil
11.5.1.2. Mexico
11.5.1.3. Rest of Latin America
11.5.2. Latin America Biodegradable Devices for IBD Market Revenue (US$ Million) Estimates and Forecasts By Type of Product, 2022-2035
11.5.3. Latin America Biodegradable Devices for IBD Market Revenue (US$ Million) Estimates and Forecasts By Application Area, 2022-2035
11.5.4. Latin America Biodegradable Devices for IBD Market Revenue (US$ Million) Estimates and Forecasts By Type of Technology, 2022-2035
11.5.5. Latin America Biodegradable Devices for IBD Market Revenue (US$ Million) Estimates and Forecasts By Type of Disease, 2022-2035
11.5.6. Latin America Biodegradable Devices for IBD Market Revenue (US$ Million) Estimates and Forecasts By Type of Material, 2022-2035
11.5.7. Latin America Biodegradable Devices for IBD Market Revenue (US$ Million) Estimates and Forecasts By End User, 2022-2035
11.6. Middle East & Africa
11.6.1. Middle East & Africa Biodegradable Devices for IBD Market Revenue (US$ Million) Estimates and Forecasts by country, 2022-2035
11.6.1.1. GCC Countries
11.6.1.2. Israel
11.6.1.3. South Africa
11.6.1.4. Rest of Middle East and Africa
11.6.2. Middle East & Africa Biodegradable Devices for IBD Market Revenue (US$ Million) Estimates and Forecasts By Type of Product, 2022-2035
11.6.3. Middle East & Africa Biodegradable Devices for IBD Market Revenue (US$ Million) Estimates and Forecasts By Application Area, 2022-2035
11.6.4. Middle East & Africa Biodegradable Devices for IBD Market Revenue (US$ Million) Estimates and Forecasts By Type of Technology, 2022-2035
11.6.5. Middle East & Africa Biodegradable Devices for IBD Market Revenue (US$ Million) Estimates and Forecasts By Type of Disease, 2022-2035
11.6.6. Middle East & Africa Biodegradable Devices for IBD Market Revenue (US$ Million) Estimates and Forecasts By Type of Material, 2022-2035
11.6.7. Middle East & Africa Biodegradable Devices for IBD Market Revenue (US$ Million) Estimates and Forecasts By End User, 2022-2035
Chapter 12. Competitive Landscape
12.1. Major Mergers and Acquisitions/Strategic Alliances
12.2. Company Profiles
12.2.1. Arthrex (US)
12.2.1.1. Business Overview
12.2.1.2. Key Product/Service
12.2.1.3. Financial Performance
12.2.1.4. Geographical Presence
12.2.1.5. Recent Developments with Business Strategy
12.2.2. Aesculap Implant Systems (US)
12.2.3. Bioretec (Finland)
12.2.4. B. Braun (Germany)
12.2.5. Conmed (US)
12.2.6. Exactech (US)
12.2.7. Integra Life Sciences (US)
12.2.8. Medtronic (Ireland)
12.2.9. Nu Vasive (US)
12.2.10. Orthofix Medical (US)
12.2.11. Osteomed (US)
12.2.12. Stryker (US)
12.2.13. Smith and Nephew (UK)
12.2.14. Wright Medical (US